Login / Signup

Applicability of commercial clinical chemistry test kits for horse serum.

Yoseph Cherinet MegerssaFikru Regassa GariFanos Tadesse Woldemariyam
Published in: BMC research notes (2021)
Blood samples were collected from 29 apparently healthy adult male horses and pooled serum was prepared. Validation comprises replication and recovery experiments. Total observable error (TEo), sigma (σ) metrics, and quality goal index (QGI) were used to support the validation studies. Intra- and inter-assay variability was 2.05% and 2.08%, 2.26% and 1.89%, 2.4% and 1.63%, for total cholesterol, urea and total protein, respectively; recovery was 99.46%, 97.32%, and 100.1% for total cholesterol, urea and total protein, respectively. TEo% for the specified analytes was within the total allowable error (TEa). All three analytes satisfied the recommended requirement (> 3σ). The QGI for urea, as it had below 6σ was 0.95 indicating imprecision and inaccuracy. The results endorse the suitability of the studied commercial test kits and illustrated the acceptance criteria for horse's serum.
Keyphrases
  • randomized controlled trial
  • clinical trial
  • high throughput
  • binding protein
  • open label
  • study protocol
  • phase iii
  • childhood cancer